{"id":"https://openalex.org/W4361937765","doi":"https://doi.org/10.1158/1078-0432.22477004","title":"Supplementary Data from Baseline Characteristics, Treatment Patterns, and Outcomes in Patients with HER2-Positive Metastatic Breast Cancer by Hormone Receptor Status from SystHERs","display_name":"Supplementary Data from Baseline Characteristics, Treatment Patterns, and Outcomes in Patients with HER2-Positive Metastatic Breast Cancer by Hormone Receptor Status from SystHERs","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361937765","doi":"https://doi.org/10.1158/1078-0432.22477004"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22477004","doi":"https://doi.org/10.1158/1078-0432.22477004","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22477004","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.22477004","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043219897","display_name":"Melody Cobleigh","orcid":"https://orcid.org/0000-0001-6385-4693","observed_orcids":["https://orcid.org/0000-0001-6385-4693"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melody Cobleigh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022422153","display_name":"Denise Aysel Yardley","orcid":"https://orcid.org/0000-0002-8664-3458","observed_orcids":["https://orcid.org/0000-0002-8664-3458","https://orcid.org/0009-0008-1720-6183"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Denise A. Yardley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044108002","display_name":"Adam Brufsky","orcid":"https://orcid.org/0000-0001-8080-7960","observed_orcids":["https://orcid.org/0000-0001-8080-7960","https://orcid.org/0009-0006-2725-3579"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adam M. Brufsky","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090188675","display_name":"Hope S. Rugo","orcid":"https://orcid.org/0000-0001-6710-4814","observed_orcids":["https://orcid.org/0000-0001-6710-4814"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hope S. Rugo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067203408","display_name":"Sandra M. Swain","orcid":"https://orcid.org/0000-0002-1320-3830","observed_orcids":["https://orcid.org/0000-0002-1320-3830"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandra M. Swain","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1320-3830","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014192243","display_name":"Peter Andrew Kaufman","orcid":"https://orcid.org/0000-0003-3677-6807","observed_orcids":["https://orcid.org/0000-0003-3677-6807"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter A. Kaufman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110083321","display_name":"Debu Tripathy","orcid":"https://orcid.org/0000-0002-5711-2404","observed_orcids":["https://orcid.org/0000-0002-5711-2404"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Debu Tripathy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068059897","display_name":"Sara Alsterlind Hurvitz","orcid":"https://orcid.org/0000-0001-7808-7191","observed_orcids":["https://orcid.org/0000-0001-7808-7191"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sara A. Hurvitz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071432873","display_name":"Joyce O\u2019Shaughnessy","orcid":"https://orcid.org/0000-0002-2955-5523","observed_orcids":["https://orcid.org/0000-0002-2955-5523","https://orcid.org/0000-0001-6764-2807"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joyce O'Shaughnessy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021270265","display_name":"Ginny Mason","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ginny Mason","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029418152","display_name":"Vincent Antao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vincent Antao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101715116","display_name":"Haocheng Li","orcid":"https://orcid.org/0000-0002-6562-1874","observed_orcids":["https://orcid.org/0000-0002-6562-1874"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Haocheng Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047843312","display_name":"Laura Kay Chu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura Chu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5020334650","display_name":"Mohammad Jahanzeb","orcid":"https://orcid.org/0000-0002-6894-9939","observed_orcids":["https://orcid.org/0000-0002-6894-9939"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohammad Jahanzeb","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.019700000062584877,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-positive-metastatic-breast-cancer","display_name":"HER2-positive metastatic breast cancer","score":0.9639999866485596},{"id":"https://openalex.org/keywords/hormone-receptor-status","display_name":"hormone receptor status","score":0.9860000014305115},{"id":"https://openalex.org/keywords/hormone-receptor-positivity","display_name":"hormone receptor positivity","score":0.6010000109672546},{"id":"https://openalex.org/keywords/primary-versus-metastatic-tumors","display_name":"primary tumor versus metastasis","score":0.7609999775886536},{"id":"https://openalex.org/keywords/first-line-systemic-treatment","display_name":"first-line systemic treatment","score":0.7940000295639038},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9869999885559082},{"id":"https://openalex.org/keywords/age","display_name":"age","score":0.4259999990463257},{"id":"https://openalex.org/keywords/race","display_name":"race","score":0.777999997138977}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.846903920173645},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.7489438056945801},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6996455192565918},{"id":"https://openalex.org/C160798450","wikidata":"https://www.wikidata.org/wiki/Q4230870","display_name":"Concordance","level":2,"score":0.5955656170845032},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5197188854217529},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4976816475391388},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43009406328201294},{"id":"https://openalex.org/C23589133","wikidata":"https://www.wikidata.org/wiki/Q412005","display_name":"Hormone receptor","level":4,"score":0.42306947708129883}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.22477004","doi":"https://doi.org/10.1158/1078-0432.22477004","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22477004","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.22477004.v1","doi":"https://doi.org/10.1158/1078-0432.22477004.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22477004.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Data_from_Baseline_Characteristics_Treatment_Patterns_and_Outcomes_in_Patients_with_HER2-Positive_Metastatic_Breast_Cancer_by_Hormone_Receptor_Status_from_SystHERs/22477004/1/files/39928502.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22477004","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Data_from_Baseline_Characteristics_Treatment_Patterns_and_Outcomes_in_Patients_with_HER2-Positive_Metastatic_Breast_Cancer_by_Hormone_Receptor_Status_from_SystHERs/22477004","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22477004","doi":"https://doi.org/10.1158/1078-0432.22477004","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22477004","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361937765.pdf","grobid_xml":"https://content.openalex.org/works/W4361937765.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2990519743","https://openalex.org/W4361959406","https://openalex.org/W2592046110","https://openalex.org/W2592894397","https://openalex.org/W3134342541","https://openalex.org/W2944603650","https://openalex.org/W4221009825","https://openalex.org/W2009509674","https://openalex.org/W4379285862","https://openalex.org/W2979515484"],"abstract_inverted_index":{"Supplemental":[0,14,46,62,82,97,115,130],"Table":[1,15,47,63],"1.":[2,84],"Baseline":[3],"demographics,":[4],"patient":[5,103],"characteristics,":[6],"and":[7,39,71,104,107,123,138],"disease":[8,31,76,105],"characteristics":[9,106],"by":[10,52,68,92,120,135],"percentage":[11,53],"HR":[12,17,35,42,54,69,95,121,136],"positivity;":[13],"2.":[16,99],"status":[18,70,122,137],"concordance":[19],"rates":[20],"in":[21,26,56,77,110,125,140],"primary":[22],"vs.":[23,74],"metastatic":[24],"tumors":[25],"patients":[27,57,78,87,111,126,141],"with":[28,58,79,88,112,127,142],"(A)":[29],"HR-positive":[30],"(n=685),":[32],"(B)":[33],"low":[34],"positivity":[36,43,55],"(1%-9%,":[37],"n=60),":[38],"(C)":[40],"moderate/high":[41],"(10%-100%,":[44],"n=550);":[45],"3.":[48,117],"First-line":[49,65],"systemic":[50,66],"treatment":[51,67],"HR-positive,":[59,89],"HER2-positive":[60,80,90,113,128,143],"MBC;":[61,81,114,129],"4.":[64,132],"de":[72],"novo":[73],"recurrent":[75],"Figure":[83,98,116,131],"Distribution":[85],"of":[86,94],"MBC":[91,144],"level":[93],"expression;":[96],"Association":[100],"between":[101],"baseline":[102],"overall":[108],"survival":[109,119,134],"Overall":[118,133],"age":[124],"race":[139]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2023-04-05T00:00:00"}